Joseph J Palamar1, Patricia Acosta2, Austin Le3, Charles M Cleland4, Lewis S Nelson5. 1. New York University School of Medicine, Department of Population Health, New York, NY, United States; Center for Drug Use and HIV/HCV Research, New York University College of Global Public Health, New York, NY, United States. Electronic address: joseph.palamar@nyulangone.org. 2. New York University School of Medicine, Department of Population Health, New York, NY, United States. 3. New York University School of Medicine, Department of Population Health, New York, NY, United States; New York University College of Dentistry, New York, NY, United States. 4. New York University School of Medicine, Department of Population Health, New York, NY, United States; Center for Drug Use and HIV/HCV Research, New York University College of Global Public Health, New York, NY, United States. 5. Rutgers University, School of Public Health, Rutgers University, Newark, NJ, United States.
Abstract
BACKGROUND: Drug use is prevalent among electronic dance music (EDM) party attendees, but research is needed to determine the extent of adverse drug-related outcomes in this population in order to better inform prevention and harm reduction efforts. METHOD: 1029 adults were surveyed entering EDM parties in New York City in 2018. Those reporting past-year use of a drug were asked if they experienced a harmful or very unpleasant effect after use in which they were concerned about their immediate safety. They were also asked about co-use of other drugs and whether they sought help. RESULTS: We estimate that a third (33.5%) of EDM party attendees have experienced a drug-related adverse effect in the past year. Two-thirds (67.8%) of adverse effects involved use of alcohol. Relative to use, adverse effects most commonly resulted from use of opioids (e.g., prescription opioid misuse, 41.2%) or alcohol (33.9%). Among those reporting an adverse effect, concomitant use of other drugs was common, particularly among users of LSD (56.5%), ketamine (56.3%), cocaine (55.7%), and ecstasy/MDMA/Molly (47.7%). Adverse effects resulting from synthetic cathinone ("bath salt") use were most likely to result in a hospital visit (57.1%). CONCLUSION: Adverse effects from drug use are common among those in the EDM party scene and polydrug use appears to be a common risk factor. More research is needed, however, to determine the extent of event-specific adverse outcomes. Results can inform prevention and harm reduction efforts in this population.
BACKGROUND: Drug use is prevalent among electronic dance music (EDM) party attendees, but research is needed to determine the extent of adverse drug-related outcomes in this population in order to better inform prevention and harm reduction efforts. METHOD: 1029 adults were surveyed entering EDM parties in New York City in 2018. Those reporting past-year use of a drug were asked if they experienced a harmful or very unpleasant effect after use in which they were concerned about their immediate safety. They were also asked about co-use of other drugs and whether they sought help. RESULTS: We estimate that a third (33.5%) of EDM party attendees have experienced a drug-related adverse effect in the past year. Two-thirds (67.8%) of adverse effects involved use of alcohol. Relative to use, adverse effects most commonly resulted from use of opioids (e.g., prescription opioid misuse, 41.2%) or alcohol (33.9%). Among those reporting an adverse effect, concomitant use of other drugs was common, particularly among users of LSD (56.5%), ketamine (56.3%), cocaine (55.7%), and ecstasy/MDMA/Molly (47.7%). Adverse effects resulting from synthetic cathinone ("bath salt") use were most likely to result in a hospital visit (57.1%). CONCLUSION: Adverse effects from drug use are common among those in the EDM party scene and polydrug use appears to be a common risk factor. More research is needed, however, to determine the extent of event-specific adverse outcomes. Results can inform prevention and harm reduction efforts in this population.
Authors: John R Richards; Timothy E Albertson; Robert W Derlet; Richard A Lange; Kent R Olson; B Zane Horowitz Journal: Drug Alcohol Depend Date: 2015-02-18 Impact factor: 4.492
Authors: Yiyang Liu; Victoria Williamson; Barry Setlow; Linda B Cottler; Lori A Knackstedt Journal: Drug Alcohol Depend Date: 2018-09-01 Impact factor: 4.492
Authors: Chicora F Oliver; Joseph J Palamar; Alberto Salomone; Steven J Simmons; Helene L Philogene-Khalid; Nick Stokes-McCloskey; Scott M Rawls Journal: Psychopharmacology (Berl) Date: 2018-10-18 Impact factor: 4.530
Authors: Kristin Feltmann; Tobias H Elgán; Anna K Strandberg; Pia Kvillemo; Nitya Jayaram-Lindström; Meryem Grabski; Jon Waldron; Tom Freeman; Helen Valerie Curran; Johanna Gripenberg Journal: Int J Environ Res Public Health Date: 2021-04-30 Impact factor: 3.390
Authors: Joseph J Palamar; Nicole D Fitzgerald; Katherine M Keyes; Linda B Cottler Journal: Exp Clin Psychopharmacol Date: 2021-02-18 Impact factor: 3.492